Foralumab Nasal

DRUG3 trials

Sponsors

Tiziana Life Sciences LTD

Conditions

ALSALS (Amyotrophic Lateral Sclerosis)ALS - Amyotrophic Lateral SclerosisMultiple System AtrophySafetyTolerability

Phase 1

Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers

CompletedNCT06879067

Tiziana Life Sciences LTDSafety, Tolerability

Start: 2018-11-12End: 2020-11-09Updated: 2025-03-17

Phase 2

A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)

RecruitingNCT06868628

Tiziana Life Sciences LTDMultiple System Atrophy

Start: 2025-05-19End: 2027-04-01Target: 5Updated: 2026-06-10

The BANYAN Trial, an ALS MyMatch Trial Evaluating Safety, Biomarker Activity, and Microglial Activation of Nasal Foralumab

Not yet recruitingNCT07688239

Tiziana Life Sciences LTDALS, ALS - Amyotrophic Lateral Sclerosis, ALS (Amyotrophic Lateral Sclerosis)

Start: 2026-07-25End: 2027-11-01Target: 44Updated: 2026-07-07